儿科医疗集团 MD
$31.29 −$0.55 (-1.73%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $31.29 0.00%
开盘$31.01
昨收$31.84
当日区间$30.84 – $31.52
成交量491.3K
市值$2.44B
市盈率（TTM）17.1
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例106.3%-0.58 个百分点，较上季度
持仓机构数364+3 ，较上季度
内部人近期交易30次买入 / 20次卖出净买入
空头持仓比例5.38% 占流通股回补天数 5.8 · 截至 15 Oct 2026
卖空成交量占比21.4%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$1.47M（7个净流入日，13个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有39.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从5.04%升至5.38%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +96,382 | 0.2% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +643,777 | 2.0% |
| LSV Asset Management | Mutual Fund | 2026/Q3 | +615,313 | 1.5% |
| Rockefeller & Co. LLC | Mutual Fund | 2026/Q3 | +576,095 | 1.7% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +566,451 | 1.2% |
| Fuller & Thaler Asset Management, Inc. | Mutual Fund | 2026/Q3 | +492,020 | 2.2% |
| Wasatch Advisors LP | Mutual Fund | 2026/Q3 | +448,360 | 3.2% |
| Tidal Investments LLC | Mutual Fund | 2026/Q3 | +441,959 | 0.8% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +363,396 | 5.3% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +244,275 | 1.4% |
| Royce & Associates, LP | Mutual Fund | 2026/Q3 | +235,578 | 1.2% |
| Edgestream Partners, L.P. | Hedge Fund | 2026/Q3 | +184,928 | 0.2% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +154,748 | 4.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +139,902 | 17.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +125,745 | 0.8% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 9 Sep 2026 | Laura McDuffie | Sale to Issuer | -6,000 | $26.82 | 33,900 | |
| 13 Aug 2026 | Sylvia Young | Independent Director | Sale to Issuer | -18,500 | $26.62 | 29,786 |
| 11 Aug 2026 | Guy Sansone | Lead Independent Director | Other Acquisition | +472 | $26.50 | 87,416 |
| 11 Aug 2026 | Thomas McEachin | Independent Director | Other Acquisition | +472 | $26.50 | 73,741 |
| 11 Aug 2026 | Sylvia Young | Independent Director | Other Acquisition | +472 | $26.50 | 48,286 |
| 11 Aug 2026 | John Starcher | Independent Director | Other Acquisition | +472 | $26.50 | 73,732 |
| 11 Aug 2026 | Shirley Weis | Independent Director | Other Acquisition | +472 | $26.50 | 19,095 |
| 11 Aug 2026 | Kurt Newman | Independent Director | Other Acquisition | +472 | $26.50 | 17,405 |
| 11 Aug 2026 | Laura McDuffie | Other Acquisition | +472 | $26.50 | 39,900 | |
| 11 Aug 2026 | Michael Rucker | Independent Director | Other Acquisition | +472 | $26.50 | 66,769 |
| 21 Jun 2026 | David Haddock | Other Acquisition | +20,036 | – | 20,036 | |
| 21 Jun 2026 | David Haddock | Other Derivative Acquisition | +51,000 | – | 51,000 | |
| 8 Jun 2026 | Mary Ann Moore | Advisor | Other Acquisition | +18,407 | – | 189,890 |
| 8 Jun 2026 | Mary Ann Moore | Advisor | Other Disposition | -18,407 | – | 189,890 |
| 1 Jun 2026 | Mark Ordan | Chairperson & CEO | Sale to Issuer | -116,293 | $21.54 | 410,884 |
| 1 Jun 2026 | Mark Ordan | Chairperson & CEO | Other Acquisition | +224,372 | – | 410,884 |
| 31 May 2026 | D. Neeb | Executive VP & Chief Operating and Strategy Officer | Sale to Issuer | -8,003 | $21.54 | 137,231 |
| 31 May 2026 | D. Neeb | Executive VP & Chief Operating and Strategy Officer | Other Acquisition | +63,888 | – | 137,231 |
| 31 May 2026 | Mary Ann Moore | Advisor | Sale to Issuer | -11,944 | $21.54 | 189,890 |
| 31 May 2026 | Kasandra Rossi | Chief Financial Officer | Sale to Issuer | -3,701 | $21.54 | 101,399 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 4,371,489 | 5.4% | 5.8 |
| 30 Sep 2026 | 4,610,228 | 5.7% | 6.1 |
| 15 Sep 2026 | 4,730,174 | 5.8% | 6.9 |
| 31 Aug 2026 | 4,817,490 | 5.9% | 6.3 |
| 14 Aug 2026 | 4,942,920 | 6.1% | 5.4 |
| 31 Jul 2026 | 4,139,091 | 5.0% | 6.6 |
暂无评论——快来第一个聊聊 MD。
登录后参与讨论。